Horizon Study

Horizon is a study that reports the safety and tolerability of ranibizumab (Lucentis) for the treatment of wet macular degeneration over a 5 year period.  Patients are currently in their 4th year of study and enrollment is closed. 

   Retina Center

Minnesota

 

Contact Us

Tel: (612) 871-2292

       (800) 233-8504

Fax: (612) 871-0195

staff@retinadocs.com